Literature DB >> 24712459

T-cell selection and intestinal homeostasis.

Teresa L Ai1, Benjamin D Solomon, Chyi-Song Hsieh.   

Abstract

Although intestinal bacteria live deep within the body, they are topographically on the exterior surface and thus outside the host. According to the classic notion that the immune system targets non-self rather than self, these intestinal bacteria should be considered foreign and therefore attacked and eliminated. While this appears to be true for some commensal bacterial species, recent data suggest that the immune system actively becomes tolerant to many bacterial organisms. The induction or activation of regulatory T (Treg) cells that inhibit, rather than promote, inflammatory responses to commensal bacteria appears to be a central component of mucosal tolerance. Loss of this mechanism can lead to inappropriate immune reactivity toward commensal organisms, perhaps contributing to mucosal inflammation characteristic of disorders such as inflammatory bowel disease.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell; T-cell receptors; inflammatory bowel disease; mucosa

Mesh:

Substances:

Year:  2014        PMID: 24712459      PMCID: PMC4028094          DOI: 10.1111/imr.12171

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  140 in total

Review 1.  Control of intestinal inflammation by regulatory T cells.

Authors:  B Singh; S Read; C Asseman; V Malmström; C Mottet; L A Stephens; R Stepankova; H Tlaskalova; F Powrie
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

2.  Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals.

Authors:  E Allison Green; Yongwon Choi; Richard A Flavell
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

3.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

4.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.

Authors:  Chrystelle Asseman; Simon Read; Fiona Powrie
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

6.  Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.

Authors:  Jonathan M Weiss; Angelina M Bilate; Michael Gobert; Yi Ding; Maria A Curotto de Lafaille; Christopher N Parkhurst; Huizhong Xiong; Jayashree Dolpady; Alan B Frey; Maria Grazia Ruocco; Yi Yang; Stefan Floess; Jochen Huehn; Soyoung Oh; Ming O Li; Rachel E Niec; Alexander Y Rudensky; Michael L Dustin; Dan R Littman; Juan J Lafaille
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

7.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

8.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

9.  In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Authors:  Qizhi Tang; Kammi J Henriksen; Mingying Bi; Erik B Finger; Greg Szot; Jianqin Ye; Emma L Masteller; Hugh McDevitt; Mark Bonyhadi; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  24 in total

1.  MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Authors:  Esen Sefik; Naama Geva-Zatorsky; Sungwhan Oh; Liza Konnikova; David Zemmour; Abigail Manson McGuire; Dalia Burzyn; Adriana Ortiz-Lopez; Mercedes Lobera; Jianfei Yang; Shomir Ghosh; Ashlee Earl; Scott B Snapper; Ray Jupp; Dennis Kasper; Diane Mathis; Christophe Benoist
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

2.  Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.

Authors:  Matthew R Hepworth; Thomas C Fung; Samuel H Masur; Judith R Kelsen; Fiona M McConnell; Juan Dubrot; David R Withers; Stephanie Hugues; Michael A Farrar; Walter Reith; Gérard Eberl; Robert N Baldassano; Terri M Laufer; Charles O Elson; Gregory F Sonnenberg
Journal:  Science       Date:  2015-04-23       Impact factor: 47.728

Review 3.  Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism.

Authors:  Clarissa Campbell; Alexander Rudensky
Journal:  Cell Metab       Date:  2019-10-10       Impact factor: 27.287

4.  Regulatory cells in health and disease.

Authors:  Andrew J Caton; Katherine A Weissler
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 5.  T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance.

Authors:  Jiani N Chai; You W Zhou; Chyi-Song Hsieh
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

Review 6.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

7.  Unstable FoxP3+ T regulatory cells in NZW mice.

Authors:  Fabien Dépis; Ho-Keun Kwon; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-14       Impact factor: 11.205

Review 8.  Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.

Authors:  Yaron Ilan
Journal:  Clin Transl Immunology       Date:  2016-01-29

Review 9.  Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes.

Authors:  Jonathan Richard White; Jody Anne Winter; Karen Robinson
Journal:  J Inflamm Res       Date:  2015-08-13

10.  Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths.

Authors:  K A Smith; K J Filbey; L A Reynolds; J P Hewitson; Y Harcus; L Boon; T Sparwasser; G Hämmerling; R M Maizels
Journal:  Mucosal Immunol       Date:  2015-08-19       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.